Matches in Nanopublications for { ?s ?p "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP646406.RATAJguYvEzeMfTRLeUHdfZBa-o-sgAEUmo4YZ5D0yRNY130_assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646406.RATAJguYvEzeMfTRLeUHdfZBa-o-sgAEUmo4YZ5D0yRNY130_provenance.
- NP852333.RAXoW1i1Of4q-jwwD_f7OdjdHOzo3qD3Dy9tfUOMdiauY130_assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852333.RAXoW1i1Of4q-jwwD_f7OdjdHOzo3qD3Dy9tfUOMdiauY130_provenance.
- NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184307.RAQHke7l4nX1xUUE1uIztXcLrrhWe2CZUyEmxOB5M8Dqs130_provenance.
- NP1184308.RAS6j4NcGhnONeIUZWTw9grJ57l0D0jDWtxQKxqRwiSiI130_assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184308.RAS6j4NcGhnONeIUZWTw9grJ57l0D0jDWtxQKxqRwiSiI130_provenance.
- assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP939843.RAoRx8imUPPC8A-LdafxfOJE6DWQV4CRltYC5xRZUoo3g130_assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939843.RAoRx8imUPPC8A-LdafxfOJE6DWQV4CRltYC5xRZUoo3g130_provenance.
- NP1184306.RAoXHEI4BGD5MUivcDxkqm_MLSH2beCA4GQ_5ryc4oxqo130_assertion description "[In cancer cell lines, SMYD3-mediated methylation of MAP3K2 at lysine 260 potentiates activation of the Ras/Raf/MEK/ERK signalling module and SMYD3 depletion synergizes with a MEK inhibitor to block Ras-driven tumorigenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184306.RAoXHEI4BGD5MUivcDxkqm_MLSH2beCA4GQ_5ryc4oxqo130_provenance.